HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Charles Atisso Selected Research

Hypoglycemia (Reactive Hypoglycemia)

8/2014Efficacy and safety of dulaglutide added onto pioglitazone and metformin versus exenatide in type 2 diabetes in a randomized controlled trial (AWARD-1).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Charles Atisso Research Topics

Disease

3Type 2 Diabetes Mellitus (MODY)
07/2015 - 08/2014
2Nausea
10/2014 - 08/2014
2Vomiting
10/2014 - 08/2014
1Dyspepsia (Indigestion)
10/2014
1Hypoglycemia (Reactive Hypoglycemia)
08/2014
1Diarrhea
08/2014

Drug/Important Bio-Agent (IBA)

3dulaglutideIBA
07/2015 - 08/2014
3Metformin (Glucophage)FDA LinkGeneric
07/2015 - 08/2014
2Pioglitazone (Actos)FDA Link
07/2015 - 08/2014
2Exenatide (Byetta)FDA Link
07/2015 - 08/2014
1Glucagon-Like Peptide 1 (GLP 1)IBA
10/2014
1LiraglutideFDA Link
10/2014
1Pharmaceutical PreparationsIBA
10/2014